Pyrimidines

Synthetic Route of 785777-87-9, As we all know, there are many different methods for the synthesis of a compound, and people can choose the synthesis method that suits their own laboratory according to the actual situation. 785777-87-9, name is 2-Bromo-4-(trifluoromethyl)pyrimidine, molecular formula is C5H2BrF3N2, The compound is widely used in many fields, so it is necessary to find a new synthetic route. The downstream synthesis method of this compound is introduced below.

[0607] Synthesis of methyl 4-(trifluoromethyl) pyrimidine-2-carboxylate: [0608] To a stirred solution of 2-bromo-4-(trifluoromethyl) pyrimidine (800 mg, 3.52 mmol) in MeOH: CH3CN (4: 1, 5 mL) under argon atmosphere was added Pd(dppf)2Cl2 (503 mg, 0.70 mmol), triethyl amine (1.0 mL, 7.04 mmol) at RT; heated to 100 C and stirred for 16 h under CO pressure. The reaction was monitored by TLC; after completion of the reaction, the volatiles were removed in vacuo to obtain the crude. The crude was purified through silica gel column chromatography using 25% EtOAc/ Hexanes to afford methyl 4-(trifluoromethyl) pyrimidine-2-carboxylate (300 mg, 41%) as Light pink solid. [0609] 1H-NMR (CDCI3, 500 MHz): delta 9.20 (d, 1H), 7.82 (d, 1H), 4.10 (s, 3H); LC-MS: 96.04%; 207 (M++l); (column; X-bridge C-18, (50 3.0 mm, 3.5 mu); RT 2.48 min. 0.05% TFA (aq.): ACN; 0.8 mL/min); TLC: 50% EtOAc/ Hexanes (R 0.3).

While traditionally a conservative industry, chemical producers will need to modernize their PR strategies to stay relevant.we look forward to future research findings about 785777-87-9, 2-Bromo-4-(trifluoromethyl)pyrimidine.

Reference:
Patent; ENVIVO PHARMACEUTICALS, INC.; RIPKA, Amy; SHAPIRO, Gideon; MCRINER, Andrew, J.; BURSAVICH, Matthew, Gregory; WO2013/142269; (2013); A1;,
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

In the next few decades, the world population will flourish. As the population grows rapidly and people all over the world use more and more resources, all industries must consider their environmental impact. 42839-09-8, name is 2-Pyrimidinemethanol, the common compound, a new synthetic route is introduced below. Recommanded Product: 42839-09-8

Synthesis of 2-(chloromethyl)pyrimidine:To a stirred solution of pyrimidin-2-ylmethanol (4.5 g 40.90 mmol) in DCM (50 mL) was added SOCl2 (10 mL) at 0 C under inert atmosphere. The reaction mixture was heated up to 50 C and stirred for 2 h. After completion of starting material (by TLC), the volatiles were evaporated under reduced pressure. The residue was quenched with ice cold water followed by saturated NaHC03 and extracted with EtOAc. Combined organic layer was dried over sodium sulphate, filtered and concentrated in vacuo to obtain the crude product. The crude material was purified by silica gel column chromatography to afford 2-(chloromethyl)pyrimidine (960 mg, 18%) as brown liquid. 1H-NMR (DMSO-d6, 400 MHz): delta 8.84 (d, 2H), 7.52 (t, 1H), 4.82 (s, 2H); Mass (ESI): 128.5 [M+l]; LC-MS: 95.09%; 129 (M++l) (column; Chromolith RP-18, (100×4.6 mm); RT 3.86 min. 5mM NH4OAc: ACN; 0.8 ml/min); TLC: 70% EtOAc/Hexane (Rf: 0.6).

The synthetic route of 42839-09-8 has been constantly updated, and we look forward to future research findings.

Reference:
Patent; ENVIVO PHARMACEUTICALS, INC.; RIPKA, Amy; SHAPIRO, Gideon; MCRINER, Andrew; WO2012/40230; (2012); A1;,
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Application of 1195-08-0, With the rapid development and complex challenges of chemical substances, the synthesis of new drugs is usually one of the most effective ways to increase yield.1195-08-0, name is 2,4-Dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde, molecular formula is C5H4N2O3, molecular weight is 140.1, as common compound, the synthetic route is as follows.

To a DMF (0.35 M) solution of 5-formyluracil (1 eq.) was added sequentially at O0C 1 – 5 bromo-3-methoxypropane (2.2 eq.) and DBU (2.2 eq.). The resulting solution was stirred at RT for 72 h. The volatiles were then removed in vacuo. The crude product mixture thus obtained was directly subjected to purification by way of column chromatography (SiCb, EtOAc) to afford the title compound as a yellow oil.

The chemical industry reduces the impact on the environment during synthesis 1195-08-0, I believe this compound will play a more active role in future production and life.

Reference:
Patent; MERCK FROSST CANADA LTD.; WO2009/140769; (2009); A1;,
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Each compound has different characteristics, and only by selecting the characteristics of the compound suitable for a specific situation can the compound be applied on a large scale. 62968-37-0, name is 4-(2-Chloropyrimidin-4-yl)morpholine. This compound has unique chemical properties. The synthetic route is as follows. COA of Formula: C8H10ClN3O

General procedure: To a solution of 32 were added 2-chloropyrimidine intermediate (3a-3e, 3g) (1 equiv) and catalytic amount of 1N HCl in AcOH. The reaction mixture and a magnetic bar were sealed in the reaction vessel of an Anton paar monowave 300 and irradiated for 2 h at 160 C. The reaction mixture was concentrated in vacuo and then diluted with H2O or saturated aqueous NaHCO3. The aqueous layer was extracted with EtOAc, and the combined organic layers were dried over MgSO4 and then concentrated in vacuo. The residue was purified by flash column chromatography on silica gel.

If you are interested in these compounds, you can also browse my other articles.Thank you for taking the time to read this article. I hope you enjoyed it, 62968-37-0, 4-(2-Chloropyrimidin-4-yl)morpholine.

Reference:
Article; Jo, Jeyun; Kim, Sou Hyun; Kim, Heegyu; Jeong, Myeonggyo; Kwak, Jae-Hwan; Taek Han, Young; Jeong, Jee-Yeong; Jung, Young-Suk; Yun, Hwayoung; Bioorganic and Medicinal Chemistry Letters; vol. 29; 1; (2019); p. 62 – 65;,
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Electric Literature of 60025-09-4 ,Some common heterocyclic compound, 60025-09-4, molecular formula is C5H3ClN4, its traditional synthetic route has been very mature, but the traditional synthetic route has various shortcomings, such as complicated route, low yield, poor purity, etc., below Introduce a new synthetic route.

Intermediate U1: tert-butyl 4-(2-{1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl}indolizin-3-yl)-1,2,3,6-tetrahydropyridine-1-carboxylate To a solution of tert-butyl 4-[2-(1-aminoethyl)indolizin-3-yl]-1,2,3,6-tetrahydropyridine-1-carboxylate Q7 (0.039 g, 0.11 mmol) in t-BuOH (1.5 mL), 4-amino-6-chloropyrimidine-5-carbonitrile (0.017 g, 0.11 mmol) was added followed by DIPEA (0.038 mL, 0.22 mmol) and the resulting mixture was heated to reflux for 3 h. The solvent was removed and the crude was partitioned between DCM/MeOH?4/1 and water; the organic phase was dried over sodium sulfate, the solvent was removed under reduced pressure and the crude was purified by flash chromatography on Biotage silica-NH SNAP cartridge (cyclohexane to cyclohexane_AcOEt=50:50) to afford title compound as a yellow oil (0.045 g, 0.098 mmol, 89% yield). MS/ESI+ 460.4 [MH]+, Rt=1.14 min (Method A).

In the field of chemistry, the synthetic routes of compounds are constantly being developed and updated. I will also mention this compound in other articles. 60025-09-4, 4-Amino-6-chloropyrimidine-5-carbonitrile, other downstream synthetic routes, hurry up and to see.

Reference:
Patent; CHIESI FARMACEUTICI S.P.A.; BIAGETTI, Matteo; ACCETTA, Alessandro; CAPELLI, Anna Maria; GUALA, Matilde; RETINI, Michele; US2015/361100; (2015); A1;,
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Reference of 1088994-22-2, As we all know, there are many different methods for the synthesis of a compound, and people can choose the synthesis method that suits their own laboratory according to the actual situation. 1088994-22-2, name is 5-Methyl-2-(pyrimidin-2-yl)benzoicacid, molecular formula is C12H10N2O2, The compound is widely used in many fields, so it is necessary to find a new synthetic route. The downstream synthesis method of this compound is introduced below.

Example 62:Compound 13: (S)-(5-(((5-chloropyridin-2-yl)amino)methyl)-6-azaspiror2.51octan-6- yl)(5-methyl-2-(pyrimidin-2-yl)phenyl)methanone (Isomer A) HPLC retention time: 9 min (150 mg)Alternatively Compound 13 was obtained by the following procedure: 5-methyl-2- (pyrimidin-2-yl)benzoic acid (428mg, 2mmol; prepared according to WO 2008147518), intermediate 34 (500mg, 2mmol) and DIPEA (0.65ml) were dissolved in DCM (5ml) at 0 C, then T3P (50% in DCM, 1.5g) was added. The mixture is stirred at reflux for 8 hours then at RT overnight. The reaction was washed with NaOH 1 M and water, dried (Na2SO4) and evaporated. The crude was purified by silica gel column chromatography (DCM to DCIWMeOH = 95/05). 180mg of the desired compound were isolated.MS (ESI); m/z 446 [MH]+1HNMR [the product is present as a mixture of conformers. The assignment refers to the major component] (CDCI3) d ppm 8.80-8.77 (m, 1 H) 8.64-8.6 (d, 1 H) 8.36- 8.31 (d, 1 H) 8.08-8.04 (m, 1 H) 7.43-7.17 (m, 3H) 7.08-7.03 (t,1 H) 6.36-6.31 (d, 1 H) 5.79 (bs, 1 H) 5.19-5.1 1 (m, 1 H) 4.00-3.89 (m, 1 H) 3.71 -3.62 (m, 1 H) 3.50-3.39 (m, 1 H) 3.37-3.21 (m, 1 H) 2.45 (s, 3H) 2.31 -2.24 (dd, 1 H) 1.99-1.88 (dt, 1 H) 1.25- 1.19 (d, 1 H) 0.75-0.68 (d, 1 H) 0.60-0.13 (m, 4H).

While traditionally a conservative industry, chemical producers will need to modernize their PR strategies to stay relevant.we look forward to future research findings about 1088994-22-2, 5-Methyl-2-(pyrimidin-2-yl)benzoicacid.

Reference:
Patent; ROTTAPHARM S.P.A.; STASI, Luigi, Piero; ROVATI, Lucio; WO2011/6960; (2011); A1;,
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Adding a certain compound to certain chemical reactions, such as: 32779-36-5, 5-Bromo-2-chloropyrimidine, can increase the reaction rate and produce products with better performance than those obtained under traditional synthetic methods. Here is a downstream synthesis route of the compound, Computed Properties of C4H2BrClN2, blongs to pyrimidines compound. Computed Properties of C4H2BrClN2

To a solution of THF (2000.0 ml) and sodium hydride (17.0 gm, 0.708 mol), was added A/-5-(4-bromophenyl)-6-(-2-hydroxyethoxy)-4-pyrimidinyl-//- propylsulfamide (100.0 gm, 0.23 mol) at 25-30°C. Stirred the content for 30 min at 25-30° C. DMF (400.0 ml) and 5-bromo-2-chloro-pyrimidine (65.0 gm; 0.033 mol) was added to the reaction mass at 25-30° C. Stirred and heated reaction mass to 60-65°C and maintain the reaction mass at 60-65° C for 2-4 hr. After completion of reaction monitored by HPLC, cooled the reaction mass to 25-30° C and 5percent w/v citric acid solution (2500.0 ml) was added. The compound was extracted twice with ethyl acetate (1500.0 ml x 2), followed by organic layer was washed with 10percent w/v brine solution (1500.0 ml). Ethyl acetate layer was concentrated at 55-60°C under reduced pressure to produce A/-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy] ethoxy]-4-pyrimidinyl]-/V-propylsulfamide as a crude residue. Obtained residue was dissolved at 65-70°C in methanol (2400.0 ml), stirred and maintained for 30 min. The resulting solution was gradually cooled to room temperature then cooled to 0-5°C and maintained reaction mass at 0-5°C for 45-60 min. Obtained solid was filtered, washed with methanol (100.0 ml), suck dried to afford crude /V-[5-(4-bromophenyl)-6-[2-[(5-bromo-2- pyrimidinyl)oxy] ethoxyJ^-pyrimidinylJ-Af-propylsulfamide [Macitentan]. [Yield = 121.5 gm; Purity (HPLC) = 99.68percent]. Purification of Macitentan ( I ) Macitentan crude (121.5 gm, 0.202 mol) wet solid was dissolved at 65-70°C in methanol (2400.0 ml) and decolorized with activated charcoal. The resulting solution was gradually cooled to room temperature then cooled to 0- 5°C and maintained for 45-60 min. Obtained solid was filtered, washed with methanol (100.0 ml), suck dried and dried under vacuum at 55-60°C to afford highly pure Macitentan. [Yield = 111.5 gm; Purity (HPLC) = 99.94percent]. (M + H)+/z= 589.0. 1H NMR (CDCIa): delta 8.49 (s, 2 H), 8.45 (s, 1H), 7.57-7.54 (m, 2H), 7.16-7.12 (m, 2H), 6.87 (s, 1 H), 5.60-5.57 (t, J = 6.24 Hz, 1 H), 4.71- 4.69 (m, 2H), 4.61-4.59 (m, 2H), 2.97-2.92 (q, 2H), 1.61-1.52 (h, J = 7.36 Hz, 2H), 0.94-0.91 (t, J = 7.36 Hz, 3H). 13C NMR (CDC ): delta 11.24, 21.97, 44.62, 64.68, 65.48, 104.80, 111.85, 121.31, 129.48, 131.35, 132.51 , 155.82, 156.41 , 159.68, 163.10, 165.75.

At the same time, in my other blogs, there are other synthetic methods of this type of compound,32779-36-5, 5-Bromo-2-chloropyrimidine, and friends who are interested can also refer to it.

Reference:
Patent; MEGAFINE PHARMA (P) LTD.; MATHAD Vijayavitthal Thippannachar; NIPHADE NAVNATH CHINTAMAN; KABRA SANJAY RAMESHWAR; JAGTAP KUNAL MADHAV; PAWAR ANIL RAMBHAU; (43 pag.)WO2016/203489; (2016); A1;,
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Related Products of 4595-59-9, The major producers of chemicals have been the Europe, Japan and China. Due to the growing call for a cleaner, greener environment, people will have to find innovative ways to maintain their relevance. Here is a compound 4595-59-9, name is 5-Bromopyrimidine. This compound has unique chemical properties. The synthetic route is as follows.

General procedure: Forthe Suzuki-Miyaura reaction, a 50 mL round-bottomed flask was charged with aryl halide(0.5 mmol), arylboronic acid (0.65 mmol), K2CO3 (1 mmol), catalyst (0.002 g; 0.0005 mmol ofPd) and water (4 mL) and stirred at appropriate temperature. The progress of the reaction wasmonitored by thin layer chromatography using aluminum coated TLC plates (Merck) underUV light. At the end of reaction, the mixture was cooled down to room temperature and theproduct diluted with water (10 mL) and extracted with ether (3 x 15 mL). The combinedextract was washed with brine (3 x 15 mL) and dried over Na2SO4. After evaporation of the solventunder reduced pressure, the residue was subjected to column chromatography with ethylacetate/hexane (1:9) as eluent to get the desired product.

While traditionally a conservative industry, chemical producers will need to modernize their PR strategies to stay relevant.we look forward to future research findings about 4595-59-9, 5-Bromopyrimidine.

Reference:
Article; Hazarika, Munmi; Borah, Debajit; Bora, Popymita; Silva, Ana R.; Das, Pankaj; PLoS ONE; vol. 12; 9; (2017);,
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Electric Literature of 22536-65-8 , The common heterocyclic compound, 22536-65-8, name is 2-Chloro-5-methoxypyrimidine, molecular formula is C5H5ClN2O, its traditional synthetic route has been very mature, but the traditional synthetic route has various shortcomings, such as complicated route, low yield, poor purity, etc., below Introduce a new synthetic route.

A) 5-methoxypyrimidine-2-carbonitrile To a solution of 2-chloro-5-methoxypyrimidine (4.4 g) and 1,4-diazabicyclo[2.2.2]octane (6.7 g) in a mixed solvent of dimethyl sulfoxide (114 mL) and water (18 mL) was added potassium cyanide (4.00 g). The reaction mixture was stirred at 70°C for 5 hr, water was added thereto, and the mixture was extracted with ethyl acetate. The extract was washed with saturated brine, and dried over sodium sulfate, and the solvent was evaporated under reduced pressure to give the title compound (3.5 g). 1H NMR (400 MHz, CDCl3) delta 4.02 (3H, s), 8.47 (2H, s).

The synthetic route of 22536-65-8 has been constantly updated, and we look forward to future research findings.

Reference:
Patent; Takeda Pharmaceutical Company Limited; MIKAMI, Satoshi; NAKAMURA, Shinji; ASHIZAWA, Tomoko; SASAKI, Shigekazu; TANIGUCHI, Takahiko; NOMURA, Izumi; KAWASAKI, Masanori; EP2848618; (2015); A1;,
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Electric Literature of 1820-81-1, In the chemical reaction process,reaction time,type of solvent,can easily affect the result of the reaction, thereby determining the yield and properties of the reaction product.An updated downstream synthesis route of 1820-81-1 as follows.

General procedure: To a solution of Thy (37 mg, 0.3 mmol), 7-MeGuo hydroiodide (191 mg, 0.45 mmol) and potassium dihydrophosphate (KH2PO4, 20 mg, 0.15 mmol) in 50mM Tris-HCl buffer, pH 7.5, 80 mL) at ambient temperature, 5 muL of 32 mg/mL E. coli purine nucleoside phosphorylase (PNP) solution (1.48 U) and 12.5 muL E. coli uridine phosphorylase (UP) (8.60 U) were added in one portion. The reaction mixture was allowed to stand for 5 h at ambient temperature under neat stirring and then allowed to stand for 15 h at ambient temperature without stirring. The conversion of the initial 7-MeGuo was controlled by HPLC. The reaction mixture was cooled to 0 C and then filtered through nitrocellulose membrane Whatman (0.2 mum, 25 mm) to remove the white precipitate of 7-methylguanine (7-MeGua). The precipitate was washed with milli-Q water (15 mL). The combined transparent filtrate was concentrated under reduced pressure using a rotary evaporator to ca. 2 mL (bath temperature (5 mL) was then added to the suspension. The resulting mixture was concentrated to near dryness and co-evaporated with ethanol (2×20 mL). The dry residue was applied on a chromatographic column (diameter 20 mm) with silica gel (20 mL) for purification. For the protection, the silica gel layer was topped with ca 0.5-cm layer of sand. The column was washed with dichloromethane (25 mL), a mixture of dichloromethane and ethanol (95:5, v/v, 50 mL), and a mixture of dichloromethane and ethanol (90:10, v/v, 100 mL). The product was eluted with dichloromethane: ethanol (80:20, v/v, 100 mL) and 10 mL fractions were collected and evaporated in vacuo to dryness. The residue was co-evaporated 5 times with dichloromethane and dried using a vacuum pump at r.t. for 1 h.

These compound has a wide range of applications. It is believed that with the continuous development of the source of the synthetic route,1820-81-1, its application will become more common.

Reference:
Article; Alexeev, Cyril S.; Drenichev, Mikhail S.; Dorinova, Evgeniya O.; Esipov, Roman S.; Kulikova, Irina V.; Mikhailov, Sergey N.; Biochimica et Biophysica Acta – Proteins and Proteomics; vol. 1868; 1; (2020);,
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia